Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature-Reference-Cited by-同舟云学术

Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature

Published:2016-07 Issue:7 Volume:16 Page:e101-e108
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Gomez Alexandra^ORCID,Hoffman James E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. Prevalence of monoclonal protein in peripheral neuropathy;Kelly;Neurology,1981

2. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies;Lunn;Cochrane Database Syst Rev,2012

3. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity;Maurer;J Clin Invest,2012

4. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients;Vital;Acta Neuropathol,1989

5. Immunofluorescence study of patients with neuropathy and IgM M proteins;Takatsu;Ann Neurol,1985

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib;Heliyon;2022-10

2. Immunochemotherapy versus rituximab in anti‐myelin‐associated glycoprotein neuropathy: A report of 64 patients;British Journal of Haematology;2022-04-14

3. Bendamustine–rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy;Journal of the Neurological Sciences;2020-06

4. Waldenstrom's macroglobulinemia in the era of immunotherapy;Leukemia & Lymphoma;2020-01-21

5. Neuropathies and paraproteins;Current Opinion in Neurology;2019-10